cupure logo
trumpstariffstradetrumptariffglobalpaymarket2025prices

Wegovy maker Novo Nordisk’s shares plunge as it cuts sales forecast

Pharma group names Maziar Mike Doustdar as new CEO as it seeks to convince investors it is not lagging behind rival Eli LilyBusiness live – latest updatesThe obesity drugmaker Novo Nordisk has cut its full-year sales and operating profit forecasts for the second time this year, sending its shares down by more than a fifth on Tuesday.The maker of the weight-loss drug Wegovy is struggling to convince investors it can remain competitive in the obesity drug boom against US rival Eli Lilly. Continue reading...

Comments

Business News